Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q3UDE2

Entry ID Method Resolution Chain Position Source
AF-Q3UDE2-F1 Predicted AlphaFoldDB

36 variants for Q3UDE2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389385625 49 H>D No EVA
rs3389342096 52 E>K No EVA
rs3389381913 79 R>W No EVA
rs31717119 83 R>K No EVA
rs3389347035 87 N>T No EVA
rs3389347053 100 S>N No EVA
rs3389376261 101 E>K No EVA
rs3413119009 104 V>I No EVA
rs3389369103 106 A>T No EVA
rs3389380779 121 C>* No EVA
rs3389393764 142 N>Y No EVA
rs3389371863 165 M>I No EVA
rs3389297603 185 V>A No EVA
rs3406067579 222 W>G No EVA
rs3389379636 258 D>N No EVA
rs3389372996 289 I>V No EVA
rs3389385630 299 V>I No EVA
rs3405820836 321 T>S No EVA
rs3405478128 325 A>G No EVA
rs3389380862 339 Y>* No EVA
rs3389340537 340 M>K No EVA
rs3389297623 348 Q>* No EVA
rs3389372960 352 N>S No EVA
rs3389393805 422 L>M No EVA
rs3389379655 438 E>K No EVA
rs3389371831 439 S>N No EVA
rs3389358296 446 K>N No EVA
rs3389347033 461 N>K No EVA
rs3389369104 474 S>P No EVA
rs3389340582 508 T>I No EVA
rs3406464522 512 Y>S No EVA
rs3389380786 552 E>V No EVA
rs3389393737 579 D>N No EVA
rs3389372961 579 D>V No EVA
rs3389380801 599 L>V No EVA
rs3389375259 619 N>S No EVA

No associated diseases with Q3UDE2

No regional properties for Q3UDE2

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q3UDE2

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Midbody
  • Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
  • Cytoplasm, cytoskeleton, spindle
  • Nucleus
  • Predominantly localizes in the cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
microtubule organizing center An intracellular structure that can catalyze gamma-tubulin-dependent microtubule nucleation and that can anchor microtubules by interacting with their minus ends, plus ends or sides.
midbody A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
spindle The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart.

4 GO annotations of molecular function

Name Definition
acid-amino acid ligase activity Catalysis of the ligation of an acid to an amino acid via a carbon-nitrogen bond, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
H4K20me3 modified histone binding Binding to a histone H4 in which the lysine residue at position 20 has been modified by trimethylation.
tubulin binding Binding to monomeric or multimeric forms of tubulin, including microtubules.

4 GO annotations of biological process

Name Definition
innate immune response Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
negative regulation of type I interferon-mediated signaling pathway Any process that decreases the rate, frequency or extent of a type I interferon-mediated signaling pathway.
protein modification process The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications). Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).
regulation of mitotic cell cycle Any process that modulates the rate or extent of progress through the mitotic cell cycle.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q14166 TTLL12 Tubulin--tyrosine ligase-like protein 12 Homo sapiens (Human) PR
Q09512 ttll-12 Tubulin--tyrosine ligase-like protein 12 Caenorhabditis elegans PR
10 20 30 40 50 60
MEIQSGPQPG SPGRAERLNA RLLDEFVSLH GPTLRASGVP ERLWGRLLHK LEHEVFDAGE
70 80 90 100 110 120
MFGIMQVEEV EEAEDEAARE AQRKQPNPGG ELCYKVIVTS ESGVRADDPN SIFLIDHAWT
130 140 150 160 170 180
CRVEHARKQL QQVPGLLHRM ANLMGIEFHG EVPSPEVVAL VLEEMWKFNQ TYQLAHGTAE
190 200 210 220 230 240
EKVPVWYIMD EFGSRIQHSD MPSFATAPFF YMPQQVAYTL LWPLRDLDTG EEVTRDFAYG
250 260 270 280 290 300
EADPLIRKCM LLPWAPADML DLSFSTPEPP AKYYQAILEE NKEKLPLAIS PVARPQGHVF
310 320 330 340 350 360
RVHCDVQQVL GHLTHPRFTF TDSEADADIF FHFSHFKDYM KLSQESPQVL LNQFPCENLL
370 380 390 400 410 420
TVKDCLASIA RRAGGPEGPP WLPRTFNLRT ELPQFVSYFQ HRERRGEDNH WICKPWNLAR
430 440 450 460 470 480
SLDTHVTNNL HSIIRHREST PKVVSKYIES PVLFLREDVG NVKFDIRYIV LLRSVRPLRL
490 500 510 520 530 540
FAYDVFWLRF SNRPFALDDL DDYEKHFTVM NYDPDVVLKQ VHYNEFIPQF EKQYPEFPWS
550 560 570 580 590 600
DVQAEIFKAF TELFQVACAK PPPMGLCDYP SSRAMYAIDL MLNWDNHPDG KRVMQPQILE
610 620 630
VNFNPDCERA CRYHPSFFND VFSTLFLDET DNCHVTRII